Business ❯Pharmaceutical Industry ❯Market Trends

Sales Performance

Eli Lilly Investor Concerns

Supply and Cost Challenges Persist for Popular Weight-Loss Drugs

Eli Lilly's Weight-Loss Drugs Drive Record Q2 Revenue Surge